ResearcherThe University of Kansas Cancer CenterNo recent work listed

Kapil N. Bhalla

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0001-5209-5126; OpenAlex author ID A5079069209.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2012: 1 paper

Papers 1

Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer. Last author DOI 10.18632/oncotarget.724 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Sreedhar Venkannagari · 1 shared paper, 2012
- Paper Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor agains… DOI 10.18632/oncotarget.724 ↗
Manuel M. Hidalgo · 1 shared paper, 2012
- Paper Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor agains… DOI 10.18632/oncotarget.724 ↗
Anirban Maitra · 1 shared paper, 2012
- Paper Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor agains… DOI 10.18632/oncotarget.724 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.